LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 82.69 | 771.67 | 9376 | 11974 | 0.7830 | 0.8801 | MN20160304_L01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 84.92 | 771.67 | 8787 | 12266 | 0.7163 | 0.8396 | MN20160304_L01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 84.92 | 771.67 | 9407 | 12266 | 0.7669 | 0.8713 | MN20160304_L01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 87.14 | 771.67 | 8757 | 12592 | 0.6954 | 0.8276 | MN20160304_L01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 87.14 | 771.67 | 9334 | 12592 | 0.7412 | 0.8567 | MN20160304_L01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 2.49 | 771.67 | 966 | 867 | 1.1132 | 2.7686 | MN20160304_L01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 2.49 | 771.67 | 768 | 867 | 0.8851 | -0.0278 | MN20160304_L01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 4.71 | 771.67 | 1090 | 956 | 1.1397 | 2.0513 | MN20160304_L01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 4.71 | 771.67 | 864 | 956 | 0.9034 | 0.4406 | MN20160304_L01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 6.94 | 771.67 | 1187 | 1045 | 1.1357 | 1.6752 | MN20160304_L01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 6.94 | 771.67 | 941 | 1045 | 0.9004 | 0.5736 | MN20160304_L01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 9.16 | 771.67 | 1276 | 1138 | 1.1208 | 1.4507 | MN20160304_L01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 9.16 | 771.67 | 1032 | 1138 | 0.9065 | 0.6788 | MN20160304_L01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 11.56 | 771.67 | 1432 | 1280 | 1.1182 | 1.3304 | MN20160304_L01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 11.56 | 771.67 | 1149 | 1280 | 0.8972 | 0.7242 | MN20160304_L01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 13.78 | 771.67 | 1595 | 1459 | 1.0927 | 1.2023 | MN20160304_L01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 13.78 | 771.67 | 1304 | 1459 | 0.8933 | 0.7691 | MN20160304_L01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 16.00 | 771.67 | 1785 | 1585 | 1.1258 | 1.2417 | MN20160304_L01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 16.00 | 771.67 | 1454 | 1585 | 0.9171 | 0.8401 | MN20160304_L01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 18.22 | 771.67 | 1916 | 1741 | 1.1003 | 1.1696 | MN20160304_L01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 18.22 | 771.67 | 1609 | 1741 | 0.9240 | 0.8698 | MN20160304_L01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 20.44 | 771.67 | 2057 | 1910 | 1.0765 | 1.1159 | MN20160304_L01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 20.44 | 771.67 | 1770 | 1910 | 0.9263 | 0.8863 | MN20160304_L01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 22.66 | 771.67 | 2280 | 2141 | 1.0647 | 1.0870 | MN20160304_L01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 22.66 | 771.67 | 1972 | 2141 | 0.9209 | 0.8911 | MN20160304_L01 | G16 |